Interestingly also delayed administration of Ang- 1-7) wAng- 1-7tive in reducing injury.
Risk factors associated with 90-day mortality were higher SOFA score on the day of cyclophosphamide administration and delayed administration of cyclophosphamide.
Also, delayed administration of RGZ prevented neutrophilia in blood (P < 0.005) and significantly decreased DNA fragmentation (P < 0.05), 72 h after MCA occlusion.
However, some clinical studies have yielded negative results, largely due to a lack of consistent preclinical data or a poor design, especially delayed administration.
Of note, while some studies showed a delayed administration of systemic antifungal therapy (SAT) was associated with increased mortality [10 12], others did not found any relationship between prognosis and the timing of initial therapy [13, 14].
This delayed administration of treatment results in a higher mortality in non-neutropenic patients than in neutropenic patients (89 vs. 60%) and may explain the high mortality observed in our cohort [24, 31].
In terms of MSC administration timing, an earlier response is believed to be more effective to clinical outcomes [36, 40], although similar results have been obtained following delayed administration in some studies.
For delayed administration, liposome-entrapped DTPA decreased hepatic, skeletal and splenic Pu levels by, respectively 68, 39 and 74% of the levels in untreated control rats (only 19, 12 and 24% with a similar dose of free DTPA).
The delayed administration did not alter the clinical course of EAE (n = 6; data not shown).
If chemotherapy was delayed, administration of bevacizumab was also delayed.
The effects of delayed administration of 0.1 mg/kg Bev are shown in Figure 3.
